Srinath Soundararajan

Srinath Soundararajan

Auto-generated profile, based on publicly available information

Srinath Soundararajan

Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CRCason B. Robbins
Cason B. Robbins
DGDilraj S. Grewal
Dilraj S. Grewal
ATAtalie C. Thompson
Atalie C. Thompson
JPJames H. Powers
James H. Powers
SSSrinath Soundararajan
Srinath Soundararajan
SFSharon Fekrat
Sharon Fekrat

1 January 2022 in Ophthalmology Retina
Verified
Journal Article
Closed access
CRCason B. Robbins
Cason B. Robbins
DGDilraj S. Grewal
Dilraj S. Grewal
ATAtalie C. Thompson
Atalie C. Thompson
SSSrinath Soundararajan
Srinath Soundararajan
SYStephen P. Yoon
Stephen P. Yoon
SFSharon Fekrat
Sharon Fekrat

28 July 2021 in Journal of Vitreoretinal Diseases
Verified
Journal Article
Closed access
PDF file
SSSrinath Soundararajan
Srinath Soundararajan
CRCason B. Robbins
Cason B. Robbins
HFHenry L. Feng
Henry L. Feng
SFSharon Fekrat
Sharon Fekrat
This work describes the clinical management and outcomes in cases of presumed infectious endophthalmitis following intravitreal injection at a tertiary academic medical center. A retrospective review took place of eyes that presented to the Duke Eye Center over a 9-year period and were diagnosed with intravitreal injection–related endophthalmitis. Clinical presentation, management, microbiologic yield, visual outcomes, and complications were abstracted from medical records. Of 23 eyes diagnosed with postinjection endophthalmitis, 52.2% underwent anterior chamber tap (33.3% of which first underwent dry needle vitreous tap), 47.8% underwent needle vitreous tap, 17.4% underwent neither, and none underwent pars plana vitrectomy (PPV) for initial management. Subsequent PPV was performed in 6 eyes (26.1%). Mean visual acuity (VA) improved by 50 Early Treatment Diabetic Retinopathy Study letters at 6 months. Eyes that underwent initial anterior chamber tap had worse presenting VA than those that did not (P = .01). Eyes undergoing subsequent PPV had worse VA at presentation (P = .02) and at 6 months (P < .001). Eyes presenting with VA of hand motion (20/8000) or worse were more likely to undergo subsequent PPV (P = .02). Eyes with intravitreal injection–related endophthalmitis presenting with VA of hand motion or worse were more likely to undergo subsequent PPV. Future studies with larger cohorts may reveal whether earlier vitrectomy should be considered in these patients.

30 January 2023 in Ophthalmology Science
Verified
Journal Article
Open access
DADennis Y. Akrobetu
Dennis Y. Akrobetu
CRCason B. Robbins
Cason B. Robbins
JMJustin P. Ma
Justin P. Ma
SSSrinath Soundararajan
Srinath Soundararajan
MQMichael S. Quist
Michael S. Quist
SFSharon Fekrat
Sharon Fekrat
To assess the intrasession repeatability of macular OCT angiography (OCTA) parameters in Alzheimer's disease (AD), mild cognitive impairment (MCI), Parkinson's disease (PD), and normal cognition (NC). Cross sectional study. Patients with a clinical diagnosis of AD, PD, MCI, or NC were imaged. Images with poor quality and of those with diabetes mellitus, glaucoma, or vitreoretinal disease were excluded from analysis. All participants were imaged using the Zeiss Cirrus HD-5000 with AngioPlex (Carl Zeiss Meditec, Software Version 11.0.0.29946) and repeat OCTA images were obtained for both eyes. Perfusion density (PFD), vessel density (VD), and Foveal avascular zone (FAZ) area were measured from 3 × 3 mm and 6 × 6 mm OCTA images centered on the fovea using an ETDRS grid overlay. Intraclass correlation coefficients were used to quantify repeatability of PFD, VD, and FAZ area measurements obtained from imaging. 3 × 3 mm scans of 22 AD, 40 MCI, 21 PD, and 26 NC participants and 6 × 6 mm scans of 29 AD, 44 MCI, 29 PD, and 30 NC participants were analyzed. Repeatability values ranged from 0.64 (0.49-0.82) for 6 × 6 mm PFD in AD participants to 0.87 (0.67-0.92) for 3 × 3 mm PFD in AD participants. No significant differences were observed in repeatability between NC participants and those with neurodegenerative disease. Overall, similar OCTA repeatability was observed between NC participants and those with neurodegeneration. Regardless of diagnostic group, macular OCTA metrics demonstrated moderate to good repeatability. The authors have no proprietary or commercial interest in any materials discussed in this article.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AKAnita Kundu
Anita Kundu
JMJustin Ma
Justin Ma
CRCason B Robbins
Cason B Robbins
PPPraruj Pant
Praruj Pant
SSSrinath Soundararajan
Srinath Soundararajan
SFSharon Fekrat
Sharon Fekrat
Background: Prior cross‐sectional studies have revealed decreased macular perfusion density (PFD) and increased peripapillary PFD in Parkinson’s disease (PD). We assess longitudinal rate of change of retinal microvascular and structural parameters in PD vs controls with normal cognition.Method: Subjects were imaged using Zeiss Cirrus HD‐5000 AngioPlex. Those with confounding medical or ocular comorbidities were excluded. Superficial capillary plexus (SCP) PFD and vessel density (VD) were assessed within ETDRS 6×6 circle, inner ring, outer ring and 3×3 circle and inner ring. SCP foveal avascular zone (FAZ) area was assessed. PFD, VD, FAZ, peripapillary retinal nerve fiber layer (RNFL), ganglion cell‐inner plexiform layer (GCIPL), and central subfield thickness (CST) were measured at 2 time points 1 year apart. Rate of change per year was calculated. Generalized estimating equations analyzed associations between rate of change of imaging parameters and PD.Result: 74 eyes of 40 patients with PD (60% male, mean age 67.47.9 years) & 149 eyes of 78 controls (28% male, mean age 70.35.8 years) were included. No demographic differences were observed between groups except higher proportion of females in controls (p = 0.001). PD had a greater decline in PFD in 6×6 circle (mean change per year = 0.021, control = 0.00, p = 0.001), 6×6 inner ring (PD = 0.018, control = 0.001, p = .007), 6×6 outer ring (PD = 0.022, control = 0.00, p = 0.001), 3×3 circle (PD = 0.016, control = 0.002, p<.001), 3×3 inner ring (PD = 0.016, control = 0.002, p<0.001). PD had greater decline in VD in 6×6 circle (mean change per year in PD = 0.72/mm, control = 0.054/mm, p = 0.006), 6×6 inner ring (PD = 0.636/mm, control = 0.048/mm, p = 0.03), 6×6 outer ring (PD = 0.746/mm, control = 0.054/mm, p = 0.005), 3×3 circle (PD = 0.939/mm, control = 0.006/mm, p<0.001), 3×3 inner ring (PD = ‐0.942/mm, control = 0.013/mm, p<0.001). PD had greater decrease in GCIPL (mean change per year in PD = 0.403µm, control = 0.128µm control, p = 0.01). There were no significant differences in rate of change in FAZ area, RNFL thickness, CST, and no significant differences in rate of change when stratified by PD severity.Conclusion: PD may be associated with more rapid loss of retinal microvascular perfusion and vessel densities and more rapid thinning of GCIPL compared to normal aging in controls with normal cognition.